Morbidity Milestones Demonstrate Long Disability-Free Survival in Parkinson's Disease Patients with Deep Brain Stimulation of the Subthalamic Nucleus.
Nils SchnalkeAgni KonitsiotiAnika FrankMartin KurzWitold H PolanskiPeter ThemannMartin WolzStephan B SobottkaHeinz ReichmannBjoern FalkenburgerLisa KlingelhoeferPublished in: Movement disorders clinical practice (2023)
On average, PD patients with STN-DBS live with their disease for a longer time, and morbidity milestones occur later in the disease course than in PD patients with MT. As judged by morbidity milestones, morbidity remains compressed into the final 5 years of life in PD patients with STN-DBS.